Curis, Inc. (CRIS) Social Stream



Curis, Inc. (CRIS): $8.88

0.29 (+3.38%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add CRIS to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#53 of 355

in industry

CURIS INC (CRIS) Price Targets From Analysts

Use the tables below to see what analysts covering CURIS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-02-28 4 $24 $15 $20.25 $13.89 45.79%
2022-03-22 4 $22 $12 $17.25 $13.89 24.19%
2022-04-01 4 $22 $12.001 $17.25 $13.89 24.19%
2022-04-05 4 $20 $10 $14.25 $13.89 2.59%
2022-06-06 4 $16 $4 $10 $13.89 -28.01%
2022-08-05 2 $16 $16 $16 $13.89 15.19%
2022-10-10 3 $16 $16 $16 $13.89 15.19%
2022-11-10 3 $9 $9 $9 $13.89 -35.21%
2023-05-05 3 $9 $3 $6 $13.89 -56.8%
2023-09-25 3 $120 $60 $90 $13.89 547.95%
2023-11-03 3 $51 $51 $51 $13.89 267.17%
2023-11-17 3 $51 $26 $38.5 $13.89 177.18%

The Trend in the Analyst Price Target


Over the past 18 months, CRIS's average price target has gone up $28.5.

Over the past 36 weeks, CRIS's average upside potential has been 2,008.45%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-14 3 9 3 6.0 0.560 971.43%
2023-09-25 3 6 3 4.5 0.429 948.95%
2023-09-25 3 120 60 90.0 0.429 20879.02%
2023-11-03 3 51 51 51.0 4.570 1015.97%
2023-11-03 3 60 51 55.5 4.570 1114.44%

CRIS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The Trend in the Broker Recommendations


CRIS's average broker recommendation rating improved by 0.17 over the prior 17 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CRIS as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, CURIS INC's number of analysts covering the stock is higher than 183.43% of them.
  • In the context of all US stocks, CURIS INC's variance in analysts' estimates is lower than -935.8% of them.
  • In the context of all US stocks, CURIS INC's upside potential (average analyst target price relative to current price) is higher than 884.95% of them.
  • CRIS has a greater average analyst price target than 967.71% of stocks in the small market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to CURIS INC are AIM, MBOT, and LCTX.

Is CRIS a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!